Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Healive® in Healthy Adults and Children
NCT07793227Phase 3Recruiting
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Aug 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis A vaccine (inactivated) in hepatitis A (HAV), sponsored by Sinovac Biotech Ltd.. Started Aug 2026; status: recruiting.
02
Drugs
hepatitis A vaccine (inactivated)
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT07793227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07793227.